54gene company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Series B | Alive

Total Raised


Last Raised

$25M | 10 mos ago

About 54gene

54gene is an online genetics platform for people of African heritage.

54gene Headquarter Location

17 Sybil Iroche St



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing 54gene

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned 54gene in 3 CB Insights research briefs, most recently on Feb 15, 2022.

Expert Collections containing 54gene

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

54gene is included in 3 Expert Collections, including Omics.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Digital Health

13,074 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Digital Health 150

150 items

The winners of the third annual CB Insights Digital Health 150.

Latest 54gene News

54gene Signs MOU with Senegal’s National Academy of Sciences and Technology; Announces Landmark SEN-GENOME Genetics Research Study

May 26, 2022

54gene Signs MOU with Senegal’s National Academy of Sciences and Technology; Announces Landmark SEN-GENOME Genetics Research Study 54gene , the health technology company advancing African genomics research for improved global health outcomes, has partnered on a new Senegal research study SEN-GENOME, which will establish a full genomic database of the Senegalese population. Under the purview of the Ministry of Higher Education and Innovation of Senegal,  a Memorandum of Understanding (MOU) was signed in Dakar with the  The National Academy of Sciences and Technology of Senegal (ANSTS)  and the Department of Human Genetics of the Faculty of Medicine, Pharmacy and Odonto-Stomatology of  Cheikh Anta Diop University, Dakar . The groundbreaking study will involve Senegal’s principal ethnolinguistic groups and will be critical in gaining an understanding of human evolutionary history and how this influences disease risk in different human populations. Studying the underlying genetic characteristics of the Senegalese population will give researchers and medical practitioners a clearer understanding of the hereditary links to health and disease in the country, as well as improving interventions for disease management and treatment. As less than 3% of genomic data at present comes from African populations, SEN-GENOME has the potential to contribute to new discoveries, for the benefit of the Senegalese, Pan-African and global populations. Through the SEN-GENOME study, Senegal will become one of the first African countries to establish a full ‘reference genome’, a database giving a full picture of the genetic characteristics of a given population. As such, Senegal is setting itself apart as an innovator in the field of genomic research. Senegal has historically been a focal point of migration from the continent and a crucial piece in the formation of the African diaspora. As such, this study has the potential to contribute significantly towards extensive and life-changing research related to the health of the world African population. In addition to important scientific discoveries, SEN-GENOME will pave the way for further research into ancestry and genealogy, providing fresh insight for people of African descent hoping to understand their ancestry. Commenting on the signing of the agreement, 54gene founder and CEO Dr. Abasi Ene-Obong said, “Africans are the most genetically diverse population and this study is a significant step in enabling  Senegal to advance the practice of Precision Medicine in the country.We’re honored to collaborate with our partners in Senegal as the country continues to consolidate leadership and innovation by becoming one of the few African countries where genomics research is a reality.” The study will recruit participants from all regions of the West African country and is expected to establish a baseline genetic characterisation of the Sengalese population. Through the collaboration, 54gene will bring its expertise and support the training of Senegalse scientists. 54gene is also committed to collaborating with their Senegalese partners on additional projects. Spokesperson for the National Academy of Sciences and Technology of Senegal, Professor Aynina Cisse, said, “SEN-GENOME is a research project initiated by the National Academy of Sciences and Techniques of Senegal (ANSTS), in collaboration with the Human Genetics Department of the Faculty of Medicine, Pharmacy and Odonto-Stomatology (UCAD). The idea germinated, following the observation made by the researchers that the reference sequence of the human genome currently used, does not reflect the genetic diversity of the African populations in general and Senegalese in particular.”  Principal Investigator and Head of Human Genetic Department of the Cheikh Anta Diop University, Dakar,  Professor Rokhaya Ndiaye Diallo commented, “The medicine of the future will depend on an understanding of the genetic heritage of each individual. The SEN-GENOME project, the first of its kind in Francophone Africa, aims to create a reference genome for Senegal, reflecting the genetic diversity of the population.This database will be used to establish personalized medicine in order to improve the diagnosis, treatment and prevention of the most common diseases. It will also allow anthropologists to better understand the socio-cultural history of our communities in the interests of national cohesion.”

54gene Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

54gene Rank

  • When was 54gene founded?

    54gene was founded in 2019.

  • Where is 54gene's headquarters?

    54gene's headquarters is located at 17 Sybil Iroche St, Lagos.

  • What is 54gene's latest funding round?

    54gene's latest funding round is Series B.

  • How much did 54gene raise?

    54gene raised a total of $44.65M.

  • Who are the investors of 54gene?

    Investors of 54gene include KdT Ventures, Ingressive Capital, Adjuvant Capital, Plexo Capital, Cathay Innovation and 15 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.